These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 13600034)

  • 1. [The P/H reaction & its value for the diagnosis of the phases of the influenza virus].
    ALBALADEJO J; BERENGUER G
    Microbiol Esp; 1958; 11(2):119-33. PubMed ID: 13600034
    [No Abstract]   [Full Text] [Related]  

  • 2. The quantative effects of cations on erythrocyte agglutination by influenza virus vaccine.
    BOGERT AB; CORBETT JJ
    J Immunol; 1958 Dec; 81(6):524-6. PubMed ID: 13611260
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the virus-host interrelationships. II. Blood group A substance and typhoid bacillus antigen as the inhibitor of influenzal hemagglutination.
    SHIRATORI T
    Yokohama Med Bull; 1953 Jun; 4(3):151-62. PubMed ID: 13137071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of an enzyme-linked immunosorbent assay for the diagnosis of lethal avian influenza virus infection].
    Lu J; Guo Y; Li Z; Cao YX; Wang Q; Wang XP; Huang JJ; Wang M; Bi SL; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):180-1. PubMed ID: 17653330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemagglutination by virus & its use in the demonstration of anti-influenza & anti-mumps viral antibiodies; tests on the antibody levels of population centers of Sardinia & Tuscany].
    PITZUS F
    Atti Accad Fisiocrit Siena Med Fis; 1957; 4():862-73. PubMed ID: 13535490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influenza immunity titer in healthy persons].
    HENNEBERG G; WAGNER L
    Z Immun exp ther; 1954 Sep; 111(4):340-53. PubMed ID: 14349064
    [No Abstract]   [Full Text] [Related]  

  • 7. Cofactor and specific antibodies against influenza viruses. I. Method of cofactor titration. Cofactor content of various animal sera.
    STYK B
    Acta Virol; 1961 Nov; 5():334-41. PubMed ID: 14039568
    [No Abstract]   [Full Text] [Related]  

  • 8. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
    Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
    J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofactor and specific antibodies against influenza viruses. II. The effect of substances destroying nonspecific inhibitors on the cofactor and on specific A2 antibodies.
    STYK B; HANA L
    Acta Virol; 1961 Nov; 5():342-50. PubMed ID: 14039567
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
    J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I
    Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of single radial hemolysis technique for diagnosis of influenza A (H5N1)].
    Guo YJ; Wang M; Zhang Y; Dong J; Wen LY; Guo JF; Li Z; Yang WZ; Yu HJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):3-6. PubMed ID: 16816850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans.
    Tang JW; Ngai KL; Chan PK
    J Med Virol; 2008 Nov; 80(11):1992-6. PubMed ID: 18814271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
    Pushko P; Tumpey TM; Van Hoeven N; Belser JA; Robinson R; Nathan M; Smith G; Wright DC; Bright RA
    Vaccine; 2007 May; 25(21):4283-90. PubMed ID: 17403562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001.
    Mokhtari-Azad T; Mohammadi H; Moosavi IA; Saadatmand Z; Nategh R
    East Mediterr Health J; 2004 May; 10(3):315-21. PubMed ID: 16212207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.